Introduction
BP Kimia Farma is a pharmaceutical company that has been serving Indonesia for over 60 years. One of its biggest factories is located in Bromo Malang, East Java. In this article, we will explore the contributions of Bromo Malang to BP Kimia Farma and how it has helped the company grow over the years.
History
Bromo Malang was established in the 1970s as a production site for chemical raw materials. It was later expanded to become a pharmaceutical factory that produces various types of drugs, such as antibiotics, anti-inflammatory, and analgesics.
Facilities
Bromo Malang is equipped with state-of-the-art facilities that meet the international standards of Good Manufacturing Practice (GMP). The factory has a total area of 40 hectares, with a production capacity of over 1 billion tablets and capsules per year.
Quality Control
BP Kimia Farma places a high emphasis on quality control. Bromo Malang has a laboratory that is equipped with advanced equipment and staffed by highly trained professionals. The laboratory conducts various tests, including raw material testing, in-process testing, and finished product testing.
Environmental Sustainability
Bromo Malang is committed to environmental sustainability. The factory has implemented various initiatives to ensure that its operations do not harm the environment. For example, it has a wastewater treatment plant that treats its wastewater before releasing it into the environment.
Employment Opportunities
Bromo Malang provides employment opportunities for the local community. The factory employs over 500 people, including production workers, laboratory technicians, and administrative staff. BP Kimia Farma also provides training and development programs for its employees to enhance their skills and knowledge.
Products
Bromo Malang produces a wide range of products, including antibiotics, anti-inflammatory, and analgesics. Some of its popular products include Ampicillin, Ciprofloxacin, and Paracetamol. The quality of its products has been recognized nationally and internationally.
Research and Development
Bromo Malang has a research and development (R&D) center that conducts research on new drugs and formulations. The R&D center works closely with universities and research institutes to develop innovative products that meet the needs of the Indonesian market.
Conclusion
Bromo Malang has played a crucial role in BP Kimia Farma’s growth over the years. Its state-of-the-art facilities, commitment to quality control, environmental sustainability, employment opportunities, and research and development initiatives have made it a valuable asset for the company. BP Kimia Farma will continue to invest in Bromo Malang to ensure that it remains a leading pharmaceutical factory in Indonesia.